Note 17 - Fair Value Disclosures (Tables)

3 Months Ended

Mar. 31, 2018

Notes Tables

Fair Value, by Balance Sheet Grouping [Table Text Block]

			Fair Value Measured at Reporting Date Using
	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At March 31, 2018:
Cash and cash equivalents	$	427,013	$	-	$	427,013	$	-	$	427,013
Other receivables	$	368,580	$	-	$	-	$	368,580	$	368,580
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC – related party	$	775,328	$	-	$	-	$	775,328	$	775,328
Loans payable	$	10,023,606	$	-	$	-	$	10,023,606	$	10,023,606
Loans payable – related parties	$	1,362,877	$	-	$	-	$	-	$	-
Convertible notes payable	$	4,242,221	$	-	$	-	$	4,456,326	$	4,456,326
Convertible notes payable – related parties	$	2,710,313	$	-	$	-	$	-	$	-

	Carrying Amount		Level 1		Level 2		Level 3		Fair Value
At December 31, 2017:
Cash and cash equivalents	$	84,978	$	-	$	84,978	$	-	$	84,978
Other receivables	$	222,562	$	-	$	-	$	222,562	$	222,562
Note receivable - related party	$	44,859	$	-	$	-	$	44,859	$	44,859
Advances to CEN Biotech Ukraine, LLC – related party	$	775,328	$	-	$	-	$	775,328	$	775,328
Loans payable	$	9,981,883	$	-	$	-	$	9,981,883	$	9,981,883
Loans payable – related parties	$	1,138,923	$	-	$	-	$	-	$	-
Convertible notes payable	$	3,670,172	$	-	$	-	$	3,831,760	$	3,831,760
Convertible notes payable – related parties	$	2,710,313	$	-	$	-	$	-	$	-